EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitLeitlinieOpen Access · CC BY 4.0

Vitamin D and Chronic Kidney Disease Association with Mineral and Bone Disorder: An Appraisal of Tangled Guidelines

Jordi Bover iD, Elisabet Massó iD, Laia Gifre, Carlo Alfieri iD, Jordi Soler-Majoral, Maria Fusaro iD, Jordi Calabia iD, Rosely Rodríguez-Pena iD, Néstor Rodríguez-Chitiva iD, Víctor López-Báez iD, Maya Sánchez-Baya, Iara da Silva und 8 weitere

Nutrients · 24.03.2023 · 15 (7) · 1576

DOI: 10.3390/nu15071576 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 24.03.2023. Verfasst von Jordi Bover und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, University Hospital Germans Trias i Pujol, 08916 Badalona, Spain. Hauptthemen laut MEDLINE: Renal Insufficiency, Chronic, Bone Diseases, Hyperparathyroidism, Secondary, Vitamin D Deficiency. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease (CKD) is a highly prevalent condition worldwide in which the kidneys lose many abilities, such as the regulation of vitamin D (VD) metabolism. Moreover, people with CKD are at a higher risk of multifactorial VD deficiency, which has been extensively associated with poor outcomes, including bone disease, cardiovascular disease, and higher mortality. Evidence is abundant in terms of the association of negative outcomes with low levels of VD, but recent studies have lowered previous high expectations regarding the beneficial effects of VD supplementation in the general population. Although controversies still exist, the diagnosis and treatment of VD have not been excluded from nephrology guidelines, and much data still supports VD supplementation in CKD patients. In this narrative review, we briefly summarize evolving controversies and useful clinical approaches, underscoring that the adverse effects of VD derivatives must be balanced against the need for effective prevention of progressive and severe secondary hyperparathyroidism. Guidelines vary, but there seems to be general agreement that VD deficiency should be avoided in CKD patients, and it is likely that one should not wait until severe SHPT is present before cautiously starting VD derivatives. Furthermore, it is emphasized that the goal should not be the complete normalization of parathyroid hormone (PTH) levels. New developments may help us to better define optimal VD and PTH at different CKD stages, but large trials are still needed to confirm that VD and precise control of these and other CKD-MBD biomarkers are unequivocally related to improved hard outcomes in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal Insufficiency, ChronicBone DiseasesHyperparathyroidism, SecondaryVitamin D DeficiencyHumansVitamin DVitaminsKidneyParathyroid HormoneMinerals

Stichwörter der Autor:innen

CKD-MBDcalcidiolcalcitriolchronic kidney diseaseosteoporosissecondary hyperparathyroidismskeletal fragilityvitamin D

Substanzen

Vitamin DVitaminsParathyroid HormoneMinerals

Autor:innen und Institutionen

  • Department of Nephrology, University Hospital Germans Trias i Pujol, 08916 Badalona, Spain.
  • REMAR-IGTP Group, Research Institute Germans Trias i Pujol, Can Ruti Campus, 08916 Badalona, Spain.
  • Rheumatology Service, University Hospital Germans Trias i Pujol, 08916 Badalona, Spain.
  • Nephrology, Dialysis and Renal Transplantation, Fondazione IRCCS Ca'Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
  • Department of Clinical Sciences and Community Health, University of Milan, 20122 Milan, Italy.
  • National Research Council (CNR), 56124 Pisa, Italy.

ORCID-Profile: Jordi Bover, Elisabet Massó, Carlo Alfieri, Maria Fusaro, Jordi Calabia, Rosely Rodríguez-Pena, Néstor Rodríguez-Chitiva, Víctor López-Báez, Jonathan S Chávez-Iñiguez, José Manuel Valdivielso, Pablo Molina

Zitieren

APA

Bover, J., Massó, E., Gifre, L., Alfieri, C., Soler-Majoral, J., Fusaro, M., Calabia, J., Rodríguez-Pena, R., Rodríguez-Chitiva, N., López-Báez, V., Sánchez-Baya, M., da Silva, I., Aguilar, A., Bustos, M. C., Rodrigues, N., Chávez-Iñiguez, J. S., Romero-González, G., Valdivielso, J. M., Molina, P., & Górriz, J. L. (2023). Vitamin D and Chronic Kidney Disease Association with Mineral and Bone Disorder: An Appraisal of Tangled Guidelines. Nutrients, 15(7), 1576. https://doi.org/10.3390/nu15071576

Vancouver

Bover J, Massó E, Gifre L, Alfieri C, Soler-Majoral J, Fusaro M, et al. Vitamin D and Chronic Kidney Disease Association with Mineral and Bone Disorder: An Appraisal of Tangled Guidelines. Nutrients. 2023;15(7):1576. doi:10.3390/nu15071576

BibTeX
@article{Bover2023,
  author = {Bover, Jordi and Massó, Elisabet and Gifre, Laia and Alfieri, Carlo and Soler-Majoral, Jordi and Fusaro, Maria and Calabia, Jordi and Rodríguez-Pena, Rosely and Rodríguez-Chitiva, Néstor and López-Báez, Víctor and Sánchez-Baya, Maya and da Silva, Iara and Aguilar, Armando and Bustos, Misael C and Rodrigues, Natacha and Chávez-Iñiguez, Jonathan S and Romero-González, Gregorio and Valdivielso, José Manuel and Molina, Pablo and Górriz, José L},
  title = {Vitamin D and Chronic Kidney Disease Association with Mineral and Bone Disorder: An Appraisal of Tangled Guidelines},
  journal = {Nutrients},
  year = {2023},
  volume = {15},
  number = {7},
  pages = {1576},
  doi = {10.3390/nu15071576}
}
Kostenlos starten →